Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The 90% Effective Dose of Remimazolam for Duodenoscopy Insertion During ERCP

NCT05053763 is registered in ClinicalTrials.gov with Jianbo Yu as lead sponsor.

NCT NCT05053763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05053763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The 90% Effective Dose of Remimazolam for Duodenoscopy Insertion During ERCP
Lead sponsor
Jianbo Yu
Phase
Not applicable
Overall status
Unknown status
Start date
September 22, 2021
Completion date
December 25, 2022
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia